R. Park

Jae Woo Park, B. Cho, I. Kwon, 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Antiangiogenic and Apoptotic Properties of a Novel Amphiphilic Folate-Heparin-Lithocholate Derivative Having Cellular Internality for Cancer Therapy

Dong Yun Lee, Y. Byun, In‐San Kim, 2007, Pharmaceutical Research.

S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer

Seung‐Mo Hong, Ho-Yyoung Lee, In-Ja Park, 2022, Clinical and translational medicine.

Induction of fibronectin gene expression by inhibitors of protein phosphatase type 2B in normal and transformed fibroblasts

In‐San Kim, Byung‐Heon Lee, R. Park, 1999, Experimental & Molecular Medicine.

Preparation and characterization of self-assembled nanoparticles based on glycol chitosan bearing adriamycin

Kwangmeyung Kim, I. Kwon, C. Park, 2006 .

FAS 1 Domain of Regulation of Tumor Angiogenesis by Fastatin , the Fourth

Byung‐Heon Lee, Ha-won Jeong, R. Park, 2005 .

Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin.

In‐San Kim, Je-Yong Choi, Byung‐Heon Lee, 2004, Experimental & molecular medicine.

RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis.

J. Park, In‐San Kim, Jung-Eun Kim, 2003, Oncogene.

Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin.

J. Park, In‐San Kim, Jung-Eun Kim, 2002, The Journal of biological chemistry.

Evaluation of the anti-tumor effects of paclitaxel-encapsulated pH-sensitive micelles

Kwangmeyung Kim, I. Kwon, D. S. Lee, 2009 .

Molecular properties of wild-type and mutant βIG-H3 proteins

Y. Bae, In‐San Kim, Jung-Eun Kim, 2002 .

Polymeric nanoparticles for protein kinase activity.

Kwangmeyung Kim, I. Kwon, In‐San Kim, 2007, Chemical communications.

Stimulation of fibronectin synthesis through the protein kinase c signaling pathway in normal and transformed human lung fibroblasts

In‐San Kim, H. Ryoo, Je-Yong Choi, 1996, Biochemistry and molecular biology international.

No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer.

J. Park, H. Jeon, S. Kam, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Null Results in Brief No Association between Haplotypes of Three Variants (Codon 81, 284, and 762) in Poly(ADP-ribose) Polymerase Gene and Risk of Primary Lung Cancer 1

J. Park, H. Jeon, S. Kam, 2003 .

betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin.

J. Park, In‐San Kim, Jung Eun Kim, 2006, Experimental & molecular medicine.

Antiangiogenic Effect of Bile Acid Acylated Heparin Derivative

Y. Byun, In‐San Kim, Kyeongsoon Park, 2006, Pharmaceutical Research.

Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect.

J. Park, In‐San Kim, Jung-Eun Kim, 2003, The Journal of biological chemistry.

Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display

Erkki Ruoslahti, Byung-Heon Lee, E. Ruoslahti, 2007, Molecular Cancer Research.

Expression patterns of bone‐related proteins during osteoblastic differentiation in MC3T3‐E1 cells

In‐San Kim, H. Ryoo, Je-Yong Choi, 1996, Journal of cellular biochemistry.

Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.

Ick Chan Kwon, Yoo-Shin Kim, Minsu Lee, 2006, Biomaterials.

Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.

Ick Chan Kwon, Kuiwon Choi, Yoo-Shin Kim, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery.

Ick Chan Kwon, Seo Young Jeong, In-San Kim, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.

Ick Chan Kwon, Yoo-Shin Kim, Seo Young Jeong, 2008, Journal of controlled release : official journal of the Controlled Release Society.

Studies on Fibronectin in Plasma and Various Effusion Fluids

In‐San Kim, R. Park, J. Jo, 1989 .

Antimetastatic Effect of an Orally Active Heparin Derivative on Experimentally Induced Metastasis

Dong Yun Lee, Y. Byun, I. Kwon, 2008, Clinical Cancer Research.

Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3

Y. Byun, I. Kwon, In‐San Kim, 2008, Molecular Cancer Therapeutics.

c-Krox Binds to Several Sites in the Promoter of Both Mouse Type I Collagen Genes

Patricia Ducy, M. Mattei, G. Karsenty, 1996, The Journal of Biological Chemistry.

DNMT3B polymorphisms and risk of primary lung cancer.

J. Park, H. Jeon, S. Kam, 2004, Carcinogenesis.

DNMT 3 B polymorphisms and risk of primary lung cancer

J. Park, H. Jeon, S. Kam, 2005 .

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition

R. Herbst, Ho-Yyoung Lee, S. Oh, 2006, Molecular Cancer Therapeutics.

inhibition independent urokinase-type plasminogen activator − factor protein-3 in lung cancer is mediated by insulin-like growth Antimetastatic activity of insulin-like growth factor binding

R. Herbst, Ho-Yyoung Lee, S. Oh, 2006 .

−93G→A polymorphism of hMLH1 and risk of primary lung cancer

J. Park, H. Jeon, S. Kam, 2004, International journal of cancer.

Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.

J. Park, Su Yeon Lee, H. Jeon, 2003, Carcinogenesis.

Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer.

J. Park, Su Yeon Lee, H. Jeon, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Polymorphisms of the DNA Repair Gene Xeroderma Pigmentosum Group A and Risk of Primary Lung Cancer 1

J. Park, Su Yeon Lee, H. Jeon, 2002 .

Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.

Dong Sun Kim, J. Park, S. Kam, 2006, Lung cancer.

Caspase 9 promoter polymorphisms and risk of primary lung cancer.

J. Park, S. Kam, In‐San Kim, 2006, Human molecular genetics.

Polymorphisms in TGF-1 gene and the risk of lung cancer

S. Kam, In‐San Kim, T. Jung, 2006 .

βig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through αvβ5 integrin

In‐San Kim, Jung-Eun Kim, J. Bae, 2006, Experimental & Molecular Medicine.

Regulation of Tumor Angiogenesis by Fastatin, the Fourth FAS1 Domain of βig-h3, via αvβ3 Integrin

In‐San Kim, Ha-won Jeong, R. Park, 2005 .

Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.

In‐San Kim, Ha-won Jeong, R. Park, 2005, Cancer research.

Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin.

In‐San Kim, Jung-Eun Kim, Je-Yong Choi, 2002, Biochemical and biophysical research communications.

Polymorphisms in Apoptosis-Related Genes and Survival of Patients with Early-Stage Non-Small-Cell Lung Cancer

H. Jeon, In‐San Kim, T. Jung, 2010, Annals of Surgical Oncology.

FAS1 Domain Protein Inhibits VEGF165-Induced Angiogenesis by Targeting the Interaction between VEGFR-2 and αvβ3 Integrin

In‐San Kim, R. Park, Kiweon Cha, 2012, Molecular Cancer Research.

Angiogenesis , Metastasis , and the Cellular Microenvironment FAS 1 DomainProtein InhibitsVEGF 165-InducedAngiogenesis by Targeting the Interaction between VEGFR-2 and a v b 3 Integrin

In‐San Kim, R. Park, Kiweon Cha, 2012 .

Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population.

Young Chul Kim, Dong Sun Kim, Chang Ho Kim, 2008, Cancer genetics and cytogenetics.

Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: A negative role for NF‐κB

In‐San Kim, R. Park, Jung‐Hwa Rhew, 2000, Journal of cellular biochemistry.

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

E. Kang, Kwangmeyung Kim, In‐San Kim, 2008, Biomaterials.

Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.

Kwangmeyung Kim, I. Kwon, A. Hoffman, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Methyl-CpG Binding Domain 1 Gene Polymorphisms and Risk of Primary Lung Cancer

J. Park, S. Kam, In‐San Kim, 2005, Cancer Epidemiology Biomarkers & Prevention.

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.

Kwangmeyung Kim, I. Kwon, In‐San Kim, 2011, ACS nano.

RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.

M. Hung, Y. Shin, Hyo-Jong Lee, 2021, The Journal of clinical investigation.

Tumor Endothelial Cell Targeted Cyclic RGD-modified Heparin Derivative: Inhibition of Angiogenesis and Tumor Growth

Y. Byun, In‐San Kim, Kyeongsoon Park, 2008, Pharmaceutical Research.

Identification of Motifs for Cell Adhesion within the Repeated Domains of Transforming Growth Factor-β-induced Gene,βig-h3 *

In‐San Kim, Jung-Eun Kim, K. Kim, 2000, The Journal of Biological Chemistry.

Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy.

In‐San Kim, Soyoun Kim, R. Park, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Polyproline‐type helical‐structured low‐molecular weight heparin (LMWH)‐taurocholate conjugate as a new angiogenesis inhibitor

Seung Woo Chung, Y. Byun, In‐San Kim, 2009, International journal of cancer.

Gas-generating polymeric microspheres for long-term and continuous in vivo ultrasound imaging.

M. Han, E. Kang, Kwangmeyung Kim, 2012, Biomaterials.

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

In‐San Kim, Y. Oh, Soyoun Kim, 2021, Experimental & Molecular Medicine.

Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs.

Soyoun Kim, R. Park, Byungheon Lee, 2021, Biomaterials.

Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.

Ick Chan Kwon, Kinam Park, Kuiwon Choi, 2010, Journal of Controlled Release.

Protein-phosphorylation-responsive polymeric nanoparticles for imaging protein kinase activities in single living cells.

Kwangmeyung Kim, I. Kwon, In‐San Kim, 2007, Angewandte Chemie.

Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.

Ick Chan Kwon, Yoo-Shin Kim, Doo Sung Lee, 2007, Journal of controlled release : official journal of the Controlled Release Society.

pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel.

Ick Chan Kwon, Yoo-Shin Kim, Doo Sung Lee, 2007, International journal of pharmaceutics.

Gene expression profile of human chondrocyte HCS-2/8 cell line by EST sequencing analysis.

In‐San Kim, H. Ryoo, Shin-Yoon Kim, 2004, Gene.

Molecular properties of wild-type and mutant betaIG-H3 proteins.

Y. Bae, In‐San Kim, Jung-Eun Kim, 2002, Investigative ophthalmology & visual science.

Liver‐Specific and Echogenic Hyaluronic Acid Nanoparticles Facilitating Liver Cancer Discrimination

Kwangmeyung Kim, I. Kwon, In‐San Kim, 2013 .

Tumoral accumulation of long-circulating, self-assembled nanoparticles and its visualization by gamma scintigraphy

I. Kwon, In‐San Kim, Y. Cho, 2008 .

Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer

J. Park, H. Jeon, S. Kam, 2005, Cancer Epidemiology Biomarkers & Prevention.

Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge.

Beom Suk Lee, Seung Woo Chung, Y. Byun, 2012, Biomaterials.

Regulation of fibronectin gene expression by cyclic AMP and phorbol myristate acetate in HT-1080 human fibrosarcoma cells

In‐San Kim, R. Park, Byungheon Lee, 1998, Experimental & Molecular Medicine.

Antagonistic regulation of protein kinase C‐induced stimulation of fibronectin synthesis by cyclic AMP in human lung fibroblasts

In‐San Kim, R. Park, K. Sohn, 1997, Biochemistry and molecular biology international.

A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1–Overexpressing Tumors In Vivo

R. Park, Lianhua Chi, Dongkyu Kim, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Advantages of the Phosphatidylserine-Recognizing Peptide PSP1 for Molecular Imaging of Tumor Apoptosis Compared with Annexin V

In‐San Kim, R. Park, Kiweon Cha, 2015, PloS one.

Double-Chambered Ferritin Platform: Dual-Function Payloads of Cytotoxic Peptides and Fluorescent Protein.

In‐San Kim, Soyoun Kim, R. Park, 2016, Biomacromolecules.

Differential gene expression analysis using paraffin‐embedded tissues after laser microdissection

G. Stein, J. Lian, In‐San Kim, 2003, Journal of cellular biochemistry.

T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via αvβ3 and α5β1 integrins

In‐San Kim, R. Park, Narendra Thapa, 2008, Experimental & Molecular Medicine.

Effects of molecular weight and structural conformation of multivalent-based elastin-like polypeptides on tumor accumulation and tissue biodistribution

Aena Yi, Young-Jin Lee, Vijaya Sarangthem, 2020, Nanotheranostics.

Methyl-CpG Binding Domain 1 Gene Polymorphisms and Risk of Primary Lung Cancer

J. Park, S. Kam, In‐San Kim, 2005, Cancer Epidemiology Biomarkers & Prevention.

Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.

Kwangmeyung Kim, I. Kwon, A. Hoffman, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.

Kinam Park, Kwangmeyung Kim, I. Kwon, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Collagen Synthesis in Fibroblasts from Keloid Lesions and Their Responses to Transforming Growth Factor-β

In‐San Kim, H. Ryoo, Je-Yong Choi, 1995 .

Polyproline‐type helical‐structured low‐molecular weight heparin (LMWH)‐taurocholate conjugate as a new angiogenesis inhibitor

Seung Woo Chung, Y. Byun, In‐San Kim, 2009, International journal of cancer.

TGFBIp/ β ig-h3 activates platelets and promotes thrombogenesis

In‐San Kim, Jung-Eun Kim, R. Park, 2009 .

Bisindolylmaleimide inhibits the PMA‐induced down‐regulation of collagen synthesis in fibroblasts

In‐San Kim, R. Park, J. Jo, 1996, Biochemistry and molecular biology international.

Transactivation of fibronectin promoter by HTLV-I Tax through NF-kappaB pathway.

R. Park, T. Yi, I. Kim, 2000, Biochemical and biophysical research communications.

Modulation of Collagen Secretion Synthesis and Associated Procollagen mRNA Level by Colchicine in Human Fibroblasts

R. Park, J. Jo, Moon-Kwan Chung, 1993, Molecules and Cells.